Companies / AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

NYSE: AIMCIK 946644OCALA, FL

Financials · FY2025

Revenue$88.0K
Net income$-13.96M
Total debt$5.71M
Cash$9.90M
Diluted EPS$-8.62
Shares outstanding30.4M

Ownership

30.4M shares outstanding · as of Aug 7, 2026
0.31%Insiders
Ownership
Insiders0.31%95,804
Institutions0.39%118,522
Public float99.30%30,227,813

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Equels Thomas KCEOCEO & President · Director
0.21%63,922
0.10%31,882

Institutional holders 13

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 5, 2026Chemerow David I.
Director
GrantCommon Stock$3.4K+3K
+436.82%
3,441
0.01% of shares
low
Mar 12, 2026Equels Thomas K
CEO
OtherCommon stock$0+25K
+64.23%
63,922
0.21% of shares
low
Mar 12, 2026Chemerow David I.
Director
OtherCommon Stock$0+25K
+726.53%
28,441
0.09% of shares
low
Mar 12, 2026Equels Thomas K
CEO
OtherSeries G Convertible Preferred Stock-25
-100.00%
0
0.00% of shares
low
Mar 6, 2026Equels Thomas K
CEO
OtherClass G Warrants+50K
50,000
0.16% of shares
low
Mar 6, 2026Equels Thomas K
CEO
OtherSeries G Convertible Preferred Stock+25
25
<0.01% of shares
low
Mar 12, 2026Chemerow David I.
Director
OtherSeries G Convertible Prefered Stock-25
-100.00%
0
0.00% of shares
low
Mar 6, 2026Chemerow David I.
Director
OtherClass G Warrants+50K
50,000
0.16% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
AIMCommon StockEquity00901B303BBG000JL6Z80